Picture of Biovica International AB logo

BIOVIC B Biovica International AB Cashflow Statement

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapNeutral

Annual cashflow statement for Biovica International AB, fiscal year end - April 30th, SEK millions except per share, conversion factor applied.

R2018
April 30th
2019
April 30th
2020
April 30th
2021
April 30th
2022
April 30th
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-18-21.5-30.3-39.4-60.1
Depreciation
Non-Cash Items0.2920.373-0.3490.1460.052
Other Non-Cash Items
Changes in Working Capital0.0970.1651.66-1.311.48
Change in Accounts Receivable
Change in Inventories
Change in Taxes Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities-14.9-18-24.8-34.4-52.1
Capital Expenditures-8.59-7.33-7.04-3.56-3.4
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items0.12600
Sale/Maturity of Investment
Other Investing Cash Flow
Cash from Investing Activities-8.46-7.33-7.04-3.56-3.4
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities0055.7143-0.136
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-23.3-25.323.9105-55.6

Or unlock with your email

Or unlock with your email